JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 57(2023) N 5 p. 802-810; DOI 10.1134/S0026893323050114 Full Text

N.V. Maluchenko1*, A.N. Korovina1, A.A. Saulina1, V.M. Studitsky1,2, A.V. Feofanov1,3

The Role of the WGR Domain in the Functions of PARP1 and PARP2

1Department of Biology, Moscow State University, Moscow, 119234 Russia
2Fox Chase Cancer Center, Philadelphia, PA 19111-2497 United States
3Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997 Russia

*mal_nat@mail.ru
Received - 2023-03-21; Revised - 2023-05-02; Accepted - 2023-05-02

The PARP1 and PARP2 proteins are members of the poly(ADP-ribose) polymerase family involved in the regulation of DNA repair and replication, RNA processing, ribosome biogenesis, transcription, cell division, and cell death. PARP1 and PARP2 are promising targets for the development of anticancer drugs and can be used in the treatment of cardiovascular, neurodegenerative, and other disorders. The WGR domain has been shown to play a central role in the functioning of PARP1 and PARP2 proteins. This review considers the mechanisms of functioning of WGR domains in the PARP1 and PARP2 proteins, which have several similar and specialized properties. Understanding these processes is of great interest to fundamental science and can contribute to the development of more effective and selective inhibitors of PARP1 and PARP2.

PARP1, PARP2, WGR, PARP1 inhibitors, PARP2 inhibitors



JMB-FOOTER RAS-JOURNALS